Renowned Chinese scientist Sun Fanglin, a key figure in cancer research, has died at the age of 58 following a battle with an undisclosed illness. Sun, director of Tongji University’s Advanced Institute of Translational Medicine, significantly advanced understanding of cellular aging and tumor formation. His research proved instrumental in developing new approaches to cancer treatment. He previously served as dean of Tongji University’s School of Life Sciences and Technology, leaving a lasting impact on the academic community. An obituary posted by the institute confirmed his death on July 10th. Sun’s work is expected to continue influencing cancer research for years to come, solidifying his legacy as a pioneer in the field.